Scott Kellen Net Worth & Insider Trades
Scott Kellen - CFO and Secretary, Diamedica Therapeutics Inc
What is Scott Kellen's Net Worth?
The current estimated net worth of Diamedica Therapeutics Inc's CFO and Secretary, Scott Kellen, is estimated to be about $78.14K . Scott Kellen owns about 32,290 units of Diamedica Therapeutics Inc common stock. In the last 5 years at Diamedica Therapeutics Inc, Scott Kellen has sold an estimated value of $0 worth.
What is Scott Kellen's Past Insider Trading?
Scott Kellen's largest purchase order was 10,000 units , worth over $39.1K on June 26, 2023. In total, Scott Kellen has made about 11 transactions over 5 years of their time at Diamedica Therapeutics Inc. Scott Kellen usually trades in June, with the busiest year in 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Scott Kellen
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Scott Kellen's Salary in 2020?
As CFO and Secretary of Diamedica Therapeutics Inc, Scott Kellen has a total base salary of $276,075 . Scott Kellen received compensation valued at about $489,303 in 2020 after becoming CFO and Secretary. The vast majority of their compensation came in the form of option awards of $119,140 , other earnings, plans or compensations of $79,238 , and other compensation of $14,850 .
What is Scott Kellen's' Mailing Address?
- Mailing address is 3405 Annapolis Lane Suite 200 Minneapolis MN 55447 MN
Diamedica Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Rick Pauls | 2020 | $455,013 | - | $190,624 | $217,716 | $14,850 | $878,203 |
| Rick Pauls | 2019 | $420,000 | - | $890,736 | $178,000 | $14,650 | $733,707 |
| Scott Kellen | 2020 | $276,075 | - | $119,140 | $79,238 | $14,850 | $489,303 |
| Scott Kellen | 2019 | $262,500 | - | $336,557 | $64,800 | $13,950 | $677,807 |
| Harry Alcorn, Jr., Pharm.D. | 2020 | $291,413 | - | $119,140 | $83,662 | $14,850 | $509,065 |
| Harry Alcorn, Jr., Pharm.D. | 2019 | $273,750 | - | $421,750 | $68,400 | $14,400 | $778,300 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
What are Diamedica Therapeutics Inc's Past Insider Trades?
Diamedica Therapeutics Inc's most recent insider trade came on November 16, 2023 by David Wambeke who bought 20,000 units worth $49.2K . In the last 5 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $12.02M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Michael Randall Giuffre, Director, Richard Pilnik, Director, and Scott Kellen, CFO and Secretary .
DiaMedica Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||